跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,792 条关于
“Shanghai Allist Pharmaceuticals”
全部
10,792
临床试验
1,394
药物
2,182
机构
2,196
资讯
5,020
去年
China's STAR Market Reforms Boost Biotech Financing as Healthgen Becomes First Company to Benefit from Resumed Rules
去年
CStone Pharmaceuticals Receives NMPA Approval for Local Manufacturing of RET Inhibitor GAVRETO in China
上个月
ArriVent Advances Firmonertinib Toward Pivotal EGFR Exon 20 NSCLC Data as ADC Pipeline Progresses
3个月前
EGFR Inhibitors Market Poised for 7.9% CAGR Growth Through 2036, Driven by Next-Generation TKIs, ADCs, and Bispecific Antibodies
5个月前
Shanghai Bao Pharmaceuticals Wins NMPA Approval to Begin Clinical Trials of World's First Recombinant Ulinastatin BJ044
去年
RAPT Therapeutics Licenses Novel Anti-IgE Antibody RPT904 for Global Development
去年
Fosun Pharma's Innovative Drug Receives Registration Acceptance in China
去年
FDA Approves Shanghai Henlius Biotech's Novel ALS Drug HLX99
去年
Henlius Receives Approval for HLX10 in China, Expanding Oncology Portfolio
去年
Roche Invests $300 Million in New Shanghai Biologics Manufacturing Facility
第 1 页，共 502 页
上一页
下一页
